{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:04:15Z","timestamp":1788318255835,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.modpat.2023.100181","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T20:43:33Z","timestamp":1680295413000},"page":"100181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinicopathologic Features and Genetic Alterations in Mixed-Type Ampullary Carcinoma"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7349-402X","authenticated-orcid":false,"given":"Jun","family":"Kawata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-1182","authenticated-orcid":false,"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2023.100181_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","article-title":"Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater","volume":"85","author":"Kimura","year":"1994","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.modpat.2023.100181_bib2","series-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"10.1016\/j.modpat.2023.100181_bib3","series-title":"WHO Classification of Tumors: Digestive System Tumours","year":"2019"},{"key":"10.1016\/j.modpat.2023.100181_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jamcollsurg.2008.01.028","article-title":"Tumors of the ampulla of Vater: histopathologic classification and predictors of survival","volume":"207","author":"Carter","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.modpat.2023.100181_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1309\/AJCPCTCUQSYI89YT","article-title":"Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications","volume":"135","author":"Kohler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.modpat.2023.100181_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jso.22090","article-title":"Clinical significance of pathologic subtype in curatively resected ampulla of Vater cancer","volume":"105","author":"Kim","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","article-title":"Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater","volume":"31","author":"Chang","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1245\/s10434-012-2603-0","article-title":"Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?","volume":"20","author":"Westgaard","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jso.23600","article-title":"Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma","volume":"110","author":"Okano","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49179-w","article-title":"The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma","volume":"9","author":"Zimmermann","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.modpat.2023.100181_bib11","article-title":"Clinicopathological prognostic factors and chemotherapeutic outcome for two histopathological types of ampulla of Vater adenocarcinoma","volume":"11","author":"Xia","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/bjs.11555","article-title":"Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study","volume":"107","author":"Moekotte","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.modpat.2023.100181_bib13","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/1078-0432.CCR-21-1906","article-title":"Genome-derived classification signature for ampullary adenocarcinoma to improve clinical cancer care","volume":"27","author":"Chakraborty","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2023.100181_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jso.24274","article-title":"Phenotypic characterization and clinical outcome in ampullary adenocarcinoma","volume":"114","author":"Asano","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jso.25311","article-title":"Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance","volume":"119","author":"Liu","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","article-title":"Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma","volume":"29","author":"Yachida","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2023.100181_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.celrep.2015.12.005","article-title":"Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation","volume":"14","author":"Gingras","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.modpat.2023.100181_bib18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/jclinpath-2019-205912","article-title":"Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas","volume":"72","author":"Harthimmer","year":"2019","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.modpat.2023.100181_bib19","series-title":"Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater. Atlas of Tumor Pathology","author":"Albores-Saveedra","year":"2000"},{"key":"10.1016\/j.modpat.2023.100181_bib20","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","article-title":"The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of Vater","volume":"38","author":"Ang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2023.100181_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SLA.0000000000001999","article-title":"Ampulla of Vater carcinoma: sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations","volume":"267","author":"Mafficini","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.modpat.2023.100181_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.oraloncology.2012.09.007","article-title":"MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma","volume":"49","author":"Mroz","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib23","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2014.58.8293","article-title":"Intratumoral heterogeneity of ALK-rearranged and ALK\/EGFR coaltered lung adenocarcinoma","volume":"33","author":"Cai","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","article-title":"Biological and therapeutic impact of intratumor heterogeneity in cancer evolution","volume":"27","author":"McGranahan","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2023.100181_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib26","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1038\/s41467-018-07261-3","article-title":"Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy","volume":"9","author":"Sharma","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2023.100181_bib27","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/cncr.28150","article-title":"High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma","volume":"119","author":"Mroz","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2023.100181_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.21037\/atm.2020.02.136","article-title":"Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma","volume":"8","author":"Hou","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.modpat.2023.100181_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.21037\/atm.2019.08.112","article-title":"Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma","volume":"7","author":"Mao","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.modpat.2023.100181_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-017-4113-z","article-title":"Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer","volume":"162","author":"Ma","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.modpat.2023.100181_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/carcin\/bgx046","article-title":"Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer","volume":"38","author":"Zhang","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.modpat.2023.100181_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000443304","article-title":"Exceptional response to nanoparticle albumin-bound paclitaxel and gemcitabine in a patient with a refractory adenocarcinoma of the ampulla of Vater","volume":"9","author":"Kapp","year":"2016","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.modpat.2023.100181_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.surg.2015.02.001","article-title":"Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater","volume":"158","author":"Schiergens","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.modpat.2023.100181_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00000478-200407000-00001","article-title":"Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an \u201cintestinal\u201d pathway of carcinogenesis in the pancreas","volume":"28","author":"Adsay","year":"2004","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:23:32Z","timestamp":1760232212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0893395223000868"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100181","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic Features and Genetic Alterations in Mixed-Type Ampullary Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100181"}}